Author(s):
Babli Khatun, Venkatesh Kamath, Muddukrishna B. S., Aravinda Pai
Email(s):
pai.aravind@gmail.com
DOI:
10.52711/0974-360X.2021.00382 
Address:
Babli Khatun1, Venkatesh Kamath2, Muddukrishna B. S.3, Aravinda Pai1*
1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India.
2Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India.
3Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2021
ABSTRACT:
In the present study, a series of novel substituted pyrazole chalcones and pyrazole oximes (CF 1-15) were synthesized and characterized. Logp values were determined to assess their hydrophobicity. MTT (methyl tetrazolium) assay was performed on A-549 (lung cancer) cell lines. The MTT assay results showed the effect of various substituents on the pyrazole template that could influence their cytotoxic effect. Out of the 15 compounds screened against A-549 cell lines, the compound CF-6 showed appreciable cytotoxicity against the standard doxorubicin.
Cite this article:
Babli Khatun, Venkatesh Kamath, Muddukrishna B. S., Aravinda Pai. Synthesis, Characterization and Anticancer Evaluation of Novel Analogues of Pyrazoles. Research Journal of Pharmacy and Technology. 2021; 14(4):2162-6. doi: 10.52711/0974-360X.2021.00382
Cite(Electronic):
Babli Khatun, Venkatesh Kamath, Muddukrishna B. S., Aravinda Pai. Synthesis, Characterization and Anticancer Evaluation of Novel Analogues of Pyrazoles. Research Journal of Pharmacy and Technology. 2021; 14(4):2162-6. doi: 10.52711/0974-360X.2021.00382 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-4-58
REFERENCES:
1. Rehman K, Tariq M, Akash MS, Gillani Z, Qazi MH. Effect of HA 14‐1 on Apoptosis‐ Regulating Proteins in HeLa Cells. Chemical Biology and Drug Design. 2014 Mar;83(3): 317-23.
2. Hejmadi M. Introduction to Cancer Biology. Bookboon; 2009.
3. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000 Jan 7;100(1): 57-70.
4. Kumar H, Saini D, Jain S, Jain N. Pyrazole scaffold: a remarkable tool in the development of anticancer agents. European Journal of Medicinal Chemistry. 2013 Dec 1;70: 248-58.
5. Zheng Y, Zheng M, Ling X, Liu Y, Xue Y, An L, Gu N, Jin M. Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole–benzimidazole derivatives as potent Aurora A/B kinase inhibitors. Bioorganic and Medicinal Chemistry Letters. 2013 Jun 15;23(12): 3523-30.
6. Li X, Wang L, Long L, Xiao J, Hu Y, Li S. Synthesis and biological evaluation of 1, 2, 4-trisubstituted imidazoles and 1, 3, 5-trisubstituted pyrazoles as inhibitors of transforming growth factor β type 1 receptor (ALK5). Bioorganic and Medicinal Chemistry Letters. 2009 Aug 15;19(16): 4868-72.
7. Kupcewicz B, Ciolkowski M, Karwowski BT, Rozalski M, Krajewska U, Lorenz IP, Mayer P, Budzisz E. Copper (II) complexes with pyrazole derivatives–synthesis, crystal structure, DFT calculations and cytotoxic activity. Journal of Molecular Structure. 2013 Nov 25;1052: 32-7.
8. Koca I, Özgür A, Coşkun KA, Tutar Y. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety. Bioorganic and Medicinal Chemistry. 2013 Jul 1;21(13): 3859-65.
9. Fan C, Su H, Zhao J, Zhao B, Zhang S, Miao J. A novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through up-regulating integrin β4 in H322 lung carcinoma cells. European Journal of Medicinal Chemistry. 2010 Apr 1;45(4): 1438-46.